1. Home
  2. CVKD vs SOS Comparison

CVKD vs SOS Comparison

Compare CVKD & SOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVKD
  • SOS
  • Stock Information
  • Founded
  • CVKD 2022
  • SOS 2004
  • Country
  • CVKD United States
  • SOS China
  • Employees
  • CVKD N/A
  • SOS N/A
  • Industry
  • CVKD Medicinal Chemicals and Botanical Products
  • SOS Finance: Consumer Services
  • Sector
  • CVKD Health Care
  • SOS Finance
  • Exchange
  • CVKD Nasdaq
  • SOS Nasdaq
  • Market Cap
  • CVKD 20.8M
  • SOS 21.0M
  • IPO Year
  • CVKD 2023
  • SOS 2017
  • Fundamental
  • Price
  • CVKD $16.17
  • SOS $7.10
  • Analyst Decision
  • CVKD Strong Buy
  • SOS
  • Analyst Count
  • CVKD 2
  • SOS 0
  • Target Price
  • CVKD $46.00
  • SOS N/A
  • AVG Volume (30 Days)
  • CVKD 79.1K
  • SOS 464.2K
  • Earning Date
  • CVKD 11-07-2024
  • SOS 12-31-2024
  • Dividend Yield
  • CVKD N/A
  • SOS N/A
  • EPS Growth
  • CVKD N/A
  • SOS N/A
  • EPS
  • CVKD N/A
  • SOS N/A
  • Revenue
  • CVKD N/A
  • SOS $111,124,000.00
  • Revenue This Year
  • CVKD N/A
  • SOS N/A
  • Revenue Next Year
  • CVKD N/A
  • SOS N/A
  • P/E Ratio
  • CVKD N/A
  • SOS N/A
  • Revenue Growth
  • CVKD N/A
  • SOS N/A
  • 52 Week Low
  • CVKD $5.40
  • SOS $6.50
  • 52 Week High
  • CVKD $32.55
  • SOS $103.20
  • Technical
  • Relative Strength Index (RSI)
  • CVKD 61.78
  • SOS 37.90
  • Support Level
  • CVKD $10.65
  • SOS $6.68
  • Resistance Level
  • CVKD $12.25
  • SOS $8.90
  • Average True Range (ATR)
  • CVKD 1.68
  • SOS 1.17
  • MACD
  • CVKD 0.32
  • SOS -0.14
  • Stochastic Oscillator
  • CVKD 76.54
  • SOS 9.98

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.

About SOS SOS Limited

SOS Ltd is a multifaceted company that leverages the power of big data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing, cryptocurrency mining, and other service. The company has has three reporting segments: Commodity trading, Cryptocurrency mining and Others. Key revenue is generated from Commodity trading.

Share on Social Networks: